menu

A National Eye Institute Initiative—Ensuring the Health of Patients and Staff in Eye Health Practices During COVID-19

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

A National Eye Institute Initiative—Ensuring the Health of Patients and Staff in Eye Health Practices During COVID-19

close
0.25 credits
15 minutes
A National Eye Institute Initiative—Ensuring the Health of Patients and Staff in Eye Health Practices During COVID-19
Restart
Resume
Read full article
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
Details
Presenters
Related
Comments
  • Overview

    Are you doing your part to help prevent the spread of infection while continuing to provide professional services essential to maintain the eye health of your patients? Do you know what best practices have been put in place to continue the care of patients during the COVID-19 pandemic and prevent the transmission of the virus? Are you doing all you can to ensure the safety of your healthcare team and patients?

    In this activity, Drs. Mark Dunbar and Diana Do discuss important strategies and steps physicians and patients can take to prevent the transmission of COVID-19 while maintaining necessary treatment regimens.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Mark T. Dunbar, OD, FAAO
    Director of Optometric Services
    Bascom Palmer Eye Institute, University of Miami
    Miami, FL 

    Consulting Fees: Allergan, Genentech, Regeneron Pharmaceuticals, Carl Zeiss
    Commercial Interest Speaker Bureau: Allergan, Genentech, Regeneron Pharmaceuticals, Carl Zeiss
    Ownership Interest: Leo Lens Pharma

    Faculty:
    Diana V. Do, MD
    Professor of Ophthalmology
    Stanford University School of Medicine
    Palo Alto, CA 

    Research Support: BioTime, Genentech, Regeneron Pharmaceuticals, Santen
    Scientific Advisory Board: Allergan, Clearside, Genentech, Kodiak, Regeneron Pharmaceuticals

    Reviewers/Content Planners/Authors:

    • Emily Chew, MD has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Libby Lurwick has nothing to disclose.
    • Robert Schneider, MSW has nothing to disclose. 
  • Learning Objective

    After participating in this educational activity, participants should be better able to:

    • Define office practices that reduce the risk of COVID-19 transmission for the patient, office staff, and eye health clinicians.
  • Target Audience

    This activity is designed to meet the educational needs of retina specialists, ophthalmologists, optometrists, ophthalmologic nurses, nurse practitioners, and physician assistants.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Learning Collaborative (GLC) and the National Eye Institute of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. GLC is accredited by the ACCME to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Providers

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research. 

    This activity is provided in partnership with the National Eye Institute, of the National Institutes of Health, of the US Department of Health and Human Services. The National Eye Health Education Program of the NEI is acknowledged for its important contributions to this initiative.

  • Commercial Support

    This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    Are you doing your part to help prevent the spread of infection while continuing to provide professional services essential to maintain the eye health of your patients? Do you know what best practices have been put in place to continue the care of patients during the COVID-19 pandemic and prevent the transmission of the virus? Are you doing all you can to ensure the safety of your healthcare team and patients?

    In this activity, Drs. Mark Dunbar and Diana Do discuss important strategies and steps physicians and patients can take to prevent the transmission of COVID-19 while maintaining necessary treatment regimens.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Mark T. Dunbar, OD, FAAO
    Director of Optometric Services
    Bascom Palmer Eye Institute, University of Miami
    Miami, FL 

    Consulting Fees: Allergan, Genentech, Regeneron Pharmaceuticals, Carl Zeiss
    Commercial Interest Speaker Bureau: Allergan, Genentech, Regeneron Pharmaceuticals, Carl Zeiss
    Ownership Interest: Leo Lens Pharma

    Faculty:
    Diana V. Do, MD
    Professor of Ophthalmology
    Stanford University School of Medicine
    Palo Alto, CA 

    Research Support: BioTime, Genentech, Regeneron Pharmaceuticals, Santen
    Scientific Advisory Board: Allergan, Clearside, Genentech, Kodiak, Regeneron Pharmaceuticals

    Reviewers/Content Planners/Authors:

    • Emily Chew, MD has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Libby Lurwick has nothing to disclose.
    • Robert Schneider, MSW has nothing to disclose. 
  • Learning Objective

    After participating in this educational activity, participants should be better able to:

    • Define office practices that reduce the risk of COVID-19 transmission for the patient, office staff, and eye health clinicians.
  • Target Audience

    This activity is designed to meet the educational needs of retina specialists, ophthalmologists, optometrists, ophthalmologic nurses, nurse practitioners, and physician assistants.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Learning Collaborative (GLC) and the National Eye Institute of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. GLC is accredited by the ACCME to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Providers

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research. 

    This activity is provided in partnership with the National Eye Institute, of the National Institutes of Health, of the US Department of Health and Human Services. The National Eye Health Education Program of the NEI is acknowledged for its important contributions to this initiative.

  • Commercial Support

    This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 10/30/20